|
Download
article
257kb
pdf? |
|
Detection of MAP Kinase Activation Using Anti-ACTIVETM
MAPK pAb
By Melanie H. Cobb, University of Texas Southwestern Medical Center*
and Erik M. Schaefer, Promega Corporation
Promega's Anti-ACTIVETM MAPK pAb provides a
novel and effective method for the study of complex signaling pathways, including
activation of the mitogen-activated protein kinase (MAPK) enzymes ERK1 and ERK2. In this
update, we demonstrate the utility of this antibody in Western blotting and
immunocytochemistry.
|
